"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","group:ch1"
"GSM2463851","microRNA profile of GBM_S1","GSM2463851","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","1","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463851/suppl/GSM2463851_20140305-s24-low_s1.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463852","microRNA profile of GBM_S2","GSM2463852","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","2","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463852/suppl/GSM2463852_20140305-s24-low_s2.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463853","microRNA profile of GBM_S3","GSM2463853","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","3","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463853/suppl/GSM2463853_20140305-s20-low_s3.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463854","microRNA profile of GBM_S6","GSM2463854","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","4","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463854/suppl/GSM2463854_20140305-s22-low_s6.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463855","microRNA profile of GBM_S7","GSM2463855","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","5","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463855/suppl/GSM2463855_20140305-s23-low_s7.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463856","microRNA profile of GBM_S8","GSM2463856","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","6","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463856/suppl/GSM2463856_20140305-s23-low_s8.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463857","microRNA profile of GBM_S9","GSM2463857","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","7","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463857/suppl/GSM2463857_20140305-s20-low_s9.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463858","microRNA profile of GBM_S11","GSM2463858","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","8","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463858/suppl/GSM2463858_20140305-s15-low_s11.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463859","microRNA profile of GBM_S12","GSM2463859","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","9","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463859/suppl/GSM2463859_20140305-s21-low_s12.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463860","microRNA profile of GBM_S13","GSM2463860","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","10","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463860/suppl/GSM2463860_20140305-s15-low_s13.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463861","microRNA profile of GBM_S14","GSM2463861","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","11","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463861/suppl/GSM2463861_20140305-s16-low_s14.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463862","microRNA profile of GBM_S16","GSM2463862","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","12","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463862/suppl/GSM2463862_20140305-s19-low_s16.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463863","microRNA profile of GBM_S17","GSM2463863","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","13","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463863/suppl/GSM2463863_20140305-s18-low_s17.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463864","microRNA profile of GBM_S18","GSM2463864","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","14","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463864/suppl/GSM2463864_20140305-s18-low_s18.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463865","microRNA profile of GBM_S19","GSM2463865","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","15","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463865/suppl/GSM2463865_20140305-s16-low_s19.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463866","microRNA profile of GBM_S20","GSM2463866","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","16","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463866/suppl/GSM2463866_20140305-s17-low_s20.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463867","microRNA profile of GBM_S27","GSM2463867","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","17","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463867/suppl/GSM2463867_20140305-s13-low_s27.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463868","microRNA profile of GBM_S28","GSM2463868","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","18","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463868/suppl/GSM2463868_20140305-s14-low_s28.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463869","microRNA profile of GBM_S30","GSM2463869","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","19","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463869/suppl/GSM2463869_20140305-s6-low_s30.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463870","microRNA profile of GBM_S31","GSM2463870","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","20","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463870/suppl/GSM2463870_20140305-s6-low_s31.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463871","microRNA profile of GBM_S35","GSM2463871","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","21","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463871/suppl/GSM2463871_20140305-s8-low_s35.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463872","microRNA profile of GBM_S41","GSM2463872","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: glioblastoma multiforme patient","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","22","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463872/suppl/GSM2463872_20140305-s3-low_s41.gpr.gz","1858","glioblastoma multiforme patient"
"GSM2463873","microRNA profile of HV_S23","GSM2463873","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: healthy volunteer","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","23","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463873/suppl/GSM2463873_20140305-s11-low_s23.gpr.gz","1858","healthy volunteer"
"GSM2463874","microRNA profile of HV_S29","GSM2463874","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: healthy volunteer","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","24","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463874/suppl/GSM2463874_20140305-s14-low_s29.gpr.gz","1858","healthy volunteer"
"GSM2463875","microRNA profile of HV_S34","GSM2463875","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: healthy volunteer","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","25","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463875/suppl/GSM2463875_20140305-s8-low_s34.gpr.gz","1858","healthy volunteer"
"GSM2463876","microRNA profile of HV_S40","GSM2463876","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: healthy volunteer","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","26","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463876/suppl/GSM2463876_20140305-s3-low_s40.gpr.gz","1858","healthy volunteer"
"GSM2463877","microRNA profile of HV_S37","GSM2463877","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: healthy volunteer","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","27","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463877/suppl/GSM2463877_20140305-s9-low_s37.gpr.gz","1858","healthy volunteer"
"GSM2463878","microRNA profile of HV_S36","GSM2463878","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: healthy volunteer","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","28","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463878/suppl/GSM2463878_20140305-s9-low_s36.gpr.gz","1858","healthy volunteer"
"GSM2463879","microRNA profile of HV_S38","GSM2463879","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: healthy volunteer","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","29","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463879/suppl/GSM2463879_20140305-s10-low_s38.gpr.gz","1858","healthy volunteer"
"GSM2463880","microRNA profile of HV_S39","GSM2463880","Public on Nov 01 2017","Jan 19 2017","Nov 01 2017","RNA","1","serum","Homo sapiens","group: healthy volunteer","total RNA","Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) according to the manufacturer’s instructions.","pCp-DY547","0.3μg of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight","9606","The labeled RNAs were hybridized to the array with a 1×hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc.,Beijing, China).","30","Quantile normalization across multiple arrays, log 2 transformation of expression levels,EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL22948","Nuoqing,,Weng","wengnq@sysucc.org.cn","15889969645","State Key Laboratory of Oncology in South China,Sun Yat-sen University","651，Dongfengdong road","Guangzhou","Guangdong","510000","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2463nnn/GSM2463880/suppl/GSM2463880_20140305-s10-low_s39.gpr.gz","1858","healthy volunteer"
